Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy

Duchenne muscular dystrophy (DMD) is a lethal muscle-wasting disease. Studies in Drosophila showed that genetic increase of the levels of the bioactive sphingolipid sphingosine-1-phosphate (S1P) or delivery of 2-acetyl-5-tetrahydroxybutyl imidazole (THI), an S1P lyase inhibitor, suppresses dystrophi...

Full description

Bibliographic Details
Main Authors: Diem-Hang Nguyen-Tran, Nitai C. Hait, Henrik Sperber, Junlin Qi, Karin Fischer, Nick Ieronimakis, Mario Pantoja, Aislinn Hays, Jeremy Allegood, Morayma Reyes, Sarah Spiegel, Hannele Ruohola-Baker
Format: Article
Language:English
Published: The Company of Biologists 2014-01-01
Series:Disease Models & Mechanisms
Subjects:
S1P
THI
dys
mdx
Online Access:http://dmm.biologists.org/content/7/1/41
id doaj-8882fdb5b28248409e6f922a2a11cbc5
record_format Article
spelling doaj-8882fdb5b28248409e6f922a2a11cbc52020-11-25T02:00:14ZengThe Company of BiologistsDisease Models & Mechanisms1754-84031754-84112014-01-0171415410.1242/dmm.013631013631Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophyDiem-Hang Nguyen-TranNitai C. HaitHenrik SperberJunlin QiKarin FischerNick IeronimakisMario PantojaAislinn HaysJeremy AllegoodMorayma ReyesSarah SpiegelHannele Ruohola-BakerDuchenne muscular dystrophy (DMD) is a lethal muscle-wasting disease. Studies in Drosophila showed that genetic increase of the levels of the bioactive sphingolipid sphingosine-1-phosphate (S1P) or delivery of 2-acetyl-5-tetrahydroxybutyl imidazole (THI), an S1P lyase inhibitor, suppresses dystrophic muscle degeneration. In the dystrophic mouse (mdx), upregulation of S1P by THI increases regeneration and muscle force. S1P can act as a ligand for S1P receptors and as a histone deacetylase (HDAC) inhibitor. Because Drosophila has no identified S1P receptors and DMD correlates with increased HDAC2 levels, we tested whether S1P action in muscle involves HDAC inhibition. Here we show that beneficial effects of THI treatment in mdx mice correlate with significantly increased nuclear S1P, decreased HDAC activity and increased acetylation of specific histone residues. Importantly, the HDAC2 target microRNA genes miR-29 and miR-1 are significantly upregulated, correlating with the downregulation of the miR-29 target Col1a1 in the diaphragm of THI-treated mdx mice. Further gene expression analysis revealed a significant THI-dependent decrease in inflammatory genes and increase in metabolic genes. Accordingly, S1P levels and functional mitochondrial activity are increased after THI treatment of differentiating C2C12 cells. S1P increases the capacity of the muscle cell to use fatty acids as an energy source, suggesting that THI treatment could be beneficial for the maintenance of energy metabolism in mdx muscles.http://dmm.biologists.org/content/7/1/41HDACS1PTHIdysDystrophinmdx
collection DOAJ
language English
format Article
sources DOAJ
author Diem-Hang Nguyen-Tran
Nitai C. Hait
Henrik Sperber
Junlin Qi
Karin Fischer
Nick Ieronimakis
Mario Pantoja
Aislinn Hays
Jeremy Allegood
Morayma Reyes
Sarah Spiegel
Hannele Ruohola-Baker
spellingShingle Diem-Hang Nguyen-Tran
Nitai C. Hait
Henrik Sperber
Junlin Qi
Karin Fischer
Nick Ieronimakis
Mario Pantoja
Aislinn Hays
Jeremy Allegood
Morayma Reyes
Sarah Spiegel
Hannele Ruohola-Baker
Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy
Disease Models & Mechanisms
HDAC
S1P
THI
dys
Dystrophin
mdx
author_facet Diem-Hang Nguyen-Tran
Nitai C. Hait
Henrik Sperber
Junlin Qi
Karin Fischer
Nick Ieronimakis
Mario Pantoja
Aislinn Hays
Jeremy Allegood
Morayma Reyes
Sarah Spiegel
Hannele Ruohola-Baker
author_sort Diem-Hang Nguyen-Tran
title Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy
title_short Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy
title_full Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy
title_fullStr Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy
title_full_unstemmed Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy
title_sort molecular mechanism of sphingosine-1-phosphate action in duchenne muscular dystrophy
publisher The Company of Biologists
series Disease Models & Mechanisms
issn 1754-8403
1754-8411
publishDate 2014-01-01
description Duchenne muscular dystrophy (DMD) is a lethal muscle-wasting disease. Studies in Drosophila showed that genetic increase of the levels of the bioactive sphingolipid sphingosine-1-phosphate (S1P) or delivery of 2-acetyl-5-tetrahydroxybutyl imidazole (THI), an S1P lyase inhibitor, suppresses dystrophic muscle degeneration. In the dystrophic mouse (mdx), upregulation of S1P by THI increases regeneration and muscle force. S1P can act as a ligand for S1P receptors and as a histone deacetylase (HDAC) inhibitor. Because Drosophila has no identified S1P receptors and DMD correlates with increased HDAC2 levels, we tested whether S1P action in muscle involves HDAC inhibition. Here we show that beneficial effects of THI treatment in mdx mice correlate with significantly increased nuclear S1P, decreased HDAC activity and increased acetylation of specific histone residues. Importantly, the HDAC2 target microRNA genes miR-29 and miR-1 are significantly upregulated, correlating with the downregulation of the miR-29 target Col1a1 in the diaphragm of THI-treated mdx mice. Further gene expression analysis revealed a significant THI-dependent decrease in inflammatory genes and increase in metabolic genes. Accordingly, S1P levels and functional mitochondrial activity are increased after THI treatment of differentiating C2C12 cells. S1P increases the capacity of the muscle cell to use fatty acids as an energy source, suggesting that THI treatment could be beneficial for the maintenance of energy metabolism in mdx muscles.
topic HDAC
S1P
THI
dys
Dystrophin
mdx
url http://dmm.biologists.org/content/7/1/41
work_keys_str_mv AT diemhangnguyentran molecularmechanismofsphingosine1phosphateactioninduchennemusculardystrophy
AT nitaichait molecularmechanismofsphingosine1phosphateactioninduchennemusculardystrophy
AT henriksperber molecularmechanismofsphingosine1phosphateactioninduchennemusculardystrophy
AT junlinqi molecularmechanismofsphingosine1phosphateactioninduchennemusculardystrophy
AT karinfischer molecularmechanismofsphingosine1phosphateactioninduchennemusculardystrophy
AT nickieronimakis molecularmechanismofsphingosine1phosphateactioninduchennemusculardystrophy
AT mariopantoja molecularmechanismofsphingosine1phosphateactioninduchennemusculardystrophy
AT aislinnhays molecularmechanismofsphingosine1phosphateactioninduchennemusculardystrophy
AT jeremyallegood molecularmechanismofsphingosine1phosphateactioninduchennemusculardystrophy
AT moraymareyes molecularmechanismofsphingosine1phosphateactioninduchennemusculardystrophy
AT sarahspiegel molecularmechanismofsphingosine1phosphateactioninduchennemusculardystrophy
AT hanneleruoholabaker molecularmechanismofsphingosine1phosphateactioninduchennemusculardystrophy
_version_ 1724961876266188800